Risperidone as a treatment for Tourette's syndrome

Journal of Clinical Psychiatry

Volumn 57, Issue 1, 1996, Pages 29-31

  Bruun, Ruth Dowling ^a   Budman, Cathy L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RISPERIDONE;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GILLES DE LA TOURETTE SYNDROME; HEADACHE; HUMAN; MALE; MUSCLE WEAKNESS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR BINDING; SEDATION; TIC; VERTIGO;

ADULT; CHILD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT DROPOUTS; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE; SEVERITY OF ILLNESS INDEX; TOURETTE SYNDROME; TREATMENT OUTCOME;

EID: 0030048922     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Shapiro AK, Shapiro ES, Bruun RD, et al. Gilles de la Tourette Syndrome. New York, NY: Raven Press; 1978
2. Shapiro AK, Shapiro ES, Fulop G, et al. Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1989;46:722-730
3. Goecz CG, Tanner CM, Klawans HL. Fluphenazine and multifocal tic disorders. Arch Neurol 1987;41:271-272
4. Ross MS, Moldofsky H. A comparison of pimozide and halopendol in the treatment of Gilles de la Tourette's syndrome. Am J Psychiatry 1978;135: 585-587
5. Shapiro AK, Shapiro ES, Fulop G. Pimozide treatment of tic and Tourette disorders. Pediatrics 1987;79:1032-1039
6. Bruun RD. Gilles de la Tourette's syndrome: an overview of clinical experience. J Am Acad Child Psychiatry 1984;23:126-133
7. Bruun RD. Dysphoric phenomena associated with haloperidol treatment of Tourette syndrome. Adv Neurol 1982;35:433-436
8. Bruun RD. Subtle and underrecognized side effects of neuroleptic treatment in children with Tourette's disorder. Am J Psychiatry 1988;145: 621-624
9. Singer HS, Rabins P, Tune LE, et al. Serum haloperidol levels m Gilles de la Tourette syndrome. Biol Psychiatry 1981;16:79-84
10. Singer HS, Gammon K, Quaskey S. Haloperidol, fluphenazine and clonidine in Tourette syndrome: controversies in treatment. Ped Neurosci 1986; 12:71-74
11. Cohen DJ, Detlor J, Young JG. et al. Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry 1980;37:1350-1357
12. Bruun RD. Clonidine treatment of Tourette syndrome. Adv Neurol 1982: 35:403-405
13. Goetz CG, Tanner CM, Wilson RS, et al. Clonidine and Gilles de la Tourette syndrome, double-blind study using objective rating methods. Ann Neurol 1987;21:307-310
14. Borison RL, Pathiraja AP, Diamond BI, et al. Risperidone: clinical safety and efficacy in schizophrenia. Psychopharmacol Bull 1992;28:213-218
15. Chouinard G, Jones B, Remington G. et al. Canadian multicenter placebocontrolled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 1993;13:25-40
16. Marder SR, Meibach RC, Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994;151:825-835
17. Van der Linden C, Bruggeman R, van Woerkom T Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: an open pilot dose-titration study with rispendone. Mov Disord 1994;9:687-688
18. Lechman JF, Riddle MA, Hardin MT, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 1989;28:566-573